source
- Cadence raises $100M Series C to advance clinical AI for autonomous medical careCadence, a health tech startup, announced a $100 million Series C financing round aimed at expanding its artificial intelligence platform. The new capital will support development of AI tools that…
- Vertex's Casgevy gene therapy receives FDA approval for children with sickle cell disease and beta-thalassemiaVertex announced that its gene therapy Casgevy has been granted FDA approval for use in pediatric patients. The decision expands the therapy's reach beyond adult indications. Casgevy is now author…